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Background. Secondary bacterial infections are an important cause of morbidity and mortality associated with influenza infec-
tions. As bacterial disease can be caused by a disturbance of the host microbiome, we examined the impact of influenza on the upper 
respiratory tract microbiome in a human challenge study.
Methods. The dynamics and ecology of the throat microbiome were examined following an experimental influenza challenge 
of 52 previously-healthy adult volunteers with influenza A/Wisconsin/67/2005 (H3N2) by intranasal inoculation; 35 healthy control 
subjects were not subjected to the viral challenge. Serial oropharyngeal samples were taken over a 30-day period, and the V1-V3 
region of the bacterial 16S ribosomal RNA sequences were amplified and sequenced to determine the composition of the microbi-
ome. The carriage of pathogens was also detected.
Results. Of the 52 challenged individuals, 43 developed proven influenza infections, 33 of whom became symptomatic. None of 
the controls developed influenza, although 22% reported symptoms. The diversity of bacterial communities remained remarkably 
stable following the acquisition of influenza, with no significant differences over time between individuals with influenza and those 
in the control group. Influenza infection was not associated with perturbation of the microbiome at the level of phylum or genus. 
There was no change in colonization rates with Streptococcus pneumoniae or Neisseria meningitidis.
Conclusions. The throat microbiota is resilient to influenza infection, indicating the robustness of the upper-airway microbiome.
Keywords. microbiome; influenza; upper respiratory tract.
Secondary bacterial infection is a major cause of the mortality 
and morbidity associated with the influenza virus [1]. Bacterial 
pneumonia caused millions of deaths during influenza epidemics 
in the 20th century [2]. For example, 94% of a group of patients 
who died in the 1918 influenza pandemic had evidence of sec-
ondary bacterial pneumonia [3], while 28% of fatalities in New 
York associated with the 2009 H1N1 influenza pandemic had 
bacterial co-infections, with most diagnosed post-mortem [4].
Several pathogens cause bacterial infection following influ-
enza. Co-infections with Haemophilus influenzae were so 
common that it was initially thought to be the cause influenza 
[5]. Streptococcus pneumoniae is the commonest influenza-as-
sociated infection [6], while cavitatory Staphylococcus aureus 
pneumonia is a severe influenza complication; secondary pneu-
monia with methicillin resistant Staphylococcus aureus emerged 
in the 2009 pandemic [7]. There is also an association between 
influenza A and Neisseria meningitidis disease [8].
Multiple mechanisms could explain the development of bac-
terial disease following influenza. The virus is cytolytic and 
induces epithelial damage, impairment of surfactant produc-
tion and muco-ciliary clearance [9, 10]. Exposure of the base-
ment membrane and matrix offers binding sites for bacteria 
[11]; glycan receptors can be revealed by viral and bacterial 
neuraminidases [12, 13]. Additionally, the increased secretion 
of galectin 1 and galectin 3 can favor the adhesion of S. pneu-
moniae and N.  meningitidis [14, 15]. Murine models indicate 
that host sialic acid, released by neuraminidases, can also act 
as a nutrient for pneumococci in the upper airway, promoting 
bacterial spread [16].
The human microbiome is a complex community that has 
co-evolved with its host. A healthy microbiota protects against 
invasion by pathogenic bacteria through colonization resis-
tance, in which the microbiota restricts the growth or attach-
ment of pathogens, either by competing for nutrients and 
ecological niches, or by direct antagonism [17].
Several factors influence the microbiome, including age, 
smoking, and antibiotic treatment [18–20]. Furthermore 
changes in the microbiota are associated with airway disease 
[21]. For example, healthy volunteers were reported to have 
a more diverse nasopharyngeal microbiome compared with 
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patients suffering from pneumonia [22], while a highly diverse 
community is found in patients with asthma, cystic fibrosis, or 
Chronic Obstructive Pulmonary Disease [23, 24]. However, lit-
tle is known about the impact of viral infection on the microbi-
ota. No specific profiles of bacteria in the upper respiratory tract 
(URT) were associated with any of 7 different viral infections, 
although an apparent decrease in the carriage of Haemophilus 
and Neisseria was observed after rhinovirus [25, 26].
To further understand secondary bacterial infections, we inves-
tigated the impact of the influenza virus on the human nasopha-
ryngeal microbiome. Using 454 pyrosequencing, we characterized 
the microbiota over a 30-day period in 52 healthy adults challenged 
with influenza A H3N2 and in 32 non-challenged individuals. This 
approach allowed us to define changes in the human microbiome fol-
lowing an influenza challenge. Furthermore, we examined whether 
influenza affected the carriage of pathogens in the upper airways.
MATERIALS AND METHODS
Study Design
The study took place in a quarantine facility with informed 
consent from volunteers, in accordance with the Declaration 
of Helsinki and with United Kingdom regulatory and ethical 
(Institutional Review Board) requirements.
Volunteers were screened before study entry. In brief, volun-
teers were healthy, with no acute or chronic medical condition; 
were between the ages of 18 and 45; were not living with anyone 
at risk of influenza complications; and had not had an influenza 
vaccine in the last 3 years. Blood samples from volunteers were 
collected before quarantine entry.
Subjects were randomly allocated to either the challenge 
(n = 52) or control group (n = 35) on day -1. On day 0, indi-
viduals in the challenge group were inoculated intranasally 
with 5.5 log10 TCID50/ml/nostril of influenza strain A/H3N2/
Wisconsin/67/2005. The control group members were not sub-
jected to challenge (Figure 1).
Clinical Monitoring and Sample Collection
Volunteers recorded symptoms daily, and vital signs were 
recorded 3 times daily. Nasopharyngeal swabs, oropharyngeal 
swabs, and venous blood were collected on days −1, 3, 6, and 
28. Respiratory specimens were analyzed by quantitative poly-
merase chain reaction (qPCR) and serological specimens were 
analysed by hemagglutination inhibition (HAI) and microneu-
tralization assays. Laboratory-confirmed influenza was defined 
as either a 4-fold or greater rise in HAI or microneutralization 
titres between day -2 and day 28 or a positive nasopharyngeal 
test by PCR.
Volunteers were classified according to symptoms and 
signs. Influenza-like illness (ILI) was defined, according to the 
Centers for Disease Control and Prevention definition, as an 
illness lasting ≥24 hours with either a temperature of >37.9°C 
or 2 or more symptoms, at least 1 of which was a respiratory 
symptom. Volunteers were labeled as symptomatic if they expe-
rienced symptoms with no fever; experienced a single symp-
tom; had ≥2 symptoms, none of which were respiratory; or 
had an illness of <24 hours. Therefore, a volunteer could have 
an ILI or be symptomatic and not be infected with influenza. 
Individuals were classified according to their symptomatology 
and tests into 3 groups: the ILIflu+ group consisted of subjects 
who received the viral challenge and had an ILI, with evidence 
of an influenza infection (n = 19); the Sflu+ group consisted of 
subjects who received the viral challenge and were symptom-
atic, with evidence of an influenza infection (n = 14); and the 
ILI/Sflu+ group consisted of individuals belonging to both these 
groups (n = 33). Those who were not challenged with influenza 
and remained asymptomatic/influenza-negative formed the AC 
(asymptomatic control) group (n = 24).
DNA Isolation and Pyrosequencing
DNA was extracted from swabs using the MoBio Power Soil iso-
lation kit (MoBio laboratories). Barcoded primers were used to 
amplify ~500 bp from the V1-V3 region of the 16S ribosomal 
RNA (rRNA) gene, as previously described [27]. Amplification 
conditions were 5 minutes at 95°C, then 25 cycles of 95°C for 
45 seconds, 53°C for 45 seconds, and 72°C for 1 minute 30 sec-
onds, with a final step of 72°C for 15 minutes. The products 
were analyzed using an Agilent 2100 Bioanalyzer after purifica-
tion with QIAquick (Qiagen) and were quantified by Quant-iT 
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Figure 1. Study timeline. Volunteers were screened prior to admission to a quarantine unit on the day before receiving an intranasal challenge of influenza A (on day 0), 
then were followed for 28 days. The volunteers were kept in quarantine for 6 days post-inoculation. Controls were screened and housed in identical conditions, but were not 
subjected to a viral challenge. Throat swabs were collected at different time points during the study (ie, on days -1, 3, 6, and 28 post-inoculation).
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Picogreen (Invitrogen). The samples were pooled at equimo-
lar concentrations and sequenced using a Roche 454 GS-FLX 
Titanium platform.
Sequence Analysis
The quality of sequences was assessed using FastQC v0.11.3 
(Babraham Institute). The pre-processing of sequences was 
performed with mothur v1.35.1 [28]. Next, we used trim.flows 
to remove sequences with mismatches in the primer sequence 
or barcode. Sequences were de-noised by shhh.flows, trimmed 
to remove primers and barcodes, then aligned to the SILVA 16S 
rRNA reference alignment using trim.seqs; chimeric sequences 
were eliminated by Uchime [29]. Sequences were used to inter-
rogate the Human Oral Microbiome Database (HOMD) v13.2 
at the 98.5% identity level using Basic Local Alignment Search 
Tool (BLAST). met the following criteria: read length >375 
nucleotides (nt). (excluding barcode and primers), no ambigu-
ous bases, or homopolymers of >8 nt.
A sequence dissimilarity distance of 0.015 was used to clus-
ter sequences into operational taxonomic units (OTUs), using 
the average neighbor algorithm. Taxonomies were assigned 
using the HOMD reference dataset. The richness of commu-
nities was calculated using the Chao1 and Catchall indices [30, 
31] and diversity was estimated with the Simpson’s inverse [32] 
and Shannon [33] indices. Good’s non-parametric estimator 
was used to assess the coverage of communities in samples 
[34]. The species diversity was examined by analyzing the beta 
diversity. Samples were adjusted to 2997 reads per sample by 
random sampling. Distance matrices were generated with the 
Jaccard Index and the thetaYC measure of dissimilarity [35], 
and by principal coordinate analysis (PCoA). Dendrograms, 
representing the relationships between samples, were analyzed 
by parsimony and UniFrac [36].
S. pneumoniae and N. meningitidis Carriage
N. meningitidis was isolated by plating to GC selective medium 
(Oxoid). A  413  bp fragment-encoding RplF was amplified, 
sequenced, and identified with PubMLST [37]. Meningococcal 
isolates were characterized by serogrouping, serotyping, and 
serosubtyping. To detect the pneumococcus, lytA qPCR was 
performed, as previously described [38].
Statistical Analyses
An analysis of alpha diversity was performed using the Kruskal-
Wallis test with Dunn’s correction for multiple comparisons. An 
analysis of molecular variance was used to evaluate differences 
in PCoAs [39]. Parsimony tests were implemented by mothur 
[40]. The linear discriminant analysis (LDA) effect size was 
used to examine differences in OTUs in the control/challenged 
groups [41]; the alpha values were set to 0.05 and a LDA score 
of 2.5 was selected. A 2-tailed Fisher exact test was applied to 
compare colonization rates.
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Figure 2. Analysis of the richness of the URT microbiome. The diversity of the microbiome was analyzed by sequencing the V1-3 region of 16S rRNA amplified from samples 
obtained from the ILI/Sflu+ (white boxes) and asymptomatic control (grey boxes) groups following the influenza A challenge. The box whisker plots extend from the 25th to 
75th percentiles, and the ends of the whiskers show the maximum and minimum values. The line in the middle of the box represents the median and the dots represent the 
outliers 1.5 greater or lower than the interquartile distance. The analysis was based on: (A) the number of OTUs; (B) Chao1 index; and (C) Shannon diversity index at baseline, 
3 (3dpi), 6 (6dpi) and 28 (28dpi) days post–influenza challenge. Abbreviations: AC, asymptomatic control; dpi, days post–influenza challenge; ILI/Sflu+, subjects who received 
viral challenge, had laboratory evidence of influenza, and had an influenza-like illness/were symptomatic; OTU, operational taxonomic units; URT, upper respiratory tract.
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RESULTS
Infection and the Development of Symptoms After Influenza Challenge
Although volunteers were screened for antibodies against influ-
enza in advance, 3 individuals in the challenge group and 3 in 
the control group had serological evidence of a prior H3N2 
infection at study entry, so were excluded from subsequent 
analyses.
Influenza infection was confirmed in 43 of the 52 individ-
uals (82%) subjected to the influenza challenge; 33 subjects 
developed symptoms, including 19 with ILI (ILIflu+). An addi-
tional 3 subjects were challenged with influenza and became 
symptomatic, but had no evidence of influenza infection. There 
were 3 other challenged individuals that remained asympto-
matic, with no evidence of influenza.
Characterization of the Pharyngeal Microbiome
A total of 2 505 196 sequences were obtained from 87 indi-
viduals (52 challenged and 35 controls) on days -1, 3, 6, and 
28. DNA extraction failed for 1 sample and amplification was 
unsuccessful from 4 samples, giving us 343 usable samples. The 
removal of chimeric sequences yielded 2 057 548 sequences.
Initially, we compared ILI/Sflu+ (n = 33) and AC (n = 24) indi-
viduals. To normalize the dataset, we took 2997 sequences from 
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Figure 3. Throat microbiota structure in the ILI/Sflu+ and asymptomatic control groups during the influenza challenge. The PCoA was based on the Thetayc index, comparing 
the community structures of samples from the ILI/Sflu+ infected group (blue open circles) and asymptomatic control (red open circles) groups at days (A) 3 and (B) 6. The cen-
troid represents the arithmetic mean for each of the groups, each dot represents the microbiota structure profile for each of the samples, while the ellipses represent the 95% 
of the samples belonging to each group. Abbreviations: ILI/Sflu+, subjects who received viral challenge, had laboratory evidence of influenza, and had an influenza-like illness/
were symptomatic; PCoA, principal co-ordinates analysis .
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Figure 4. LEfSe analysis of abundant OTUs in ILI/Sflu+ and asymptomatic controls. The positive scale indicates the LDA score (Log10) for the most abundant taxa in the ILI/
Sflu+ group (green bars), while the negative scale represents the LDA scores for the prevalent taxa in the asymptomatic control group on days (A) 3 and (B) 6. Abbreviations: 
ILI/Sflu+, subjects who received viral challenge, had laboratory evidence of influenza, and had an influenza-like illness/were symptomatic; LDA, Linear Discriminant Analysis; 
LEfSe, LDA effect size; OTU, operational taxonomic units.
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each sample; 11 samples had fewer than this, so were excluded, 
leaving 213 samples. We identified 2209 OTUs (based on <98.5% 
of identity, >4 representatives), with 24% of sequences falling into 
3 OTUs: OTU1 (accounting for 9.78% of sequences), with pre-
dominant member Fusobacterium periodonticum; OTU2 (7.8%), 
with predominant members S.  salivarus/S.  vestibularis; and 
OTU3 (7%), with predominant members S. mitis/S. pneumoniae.
Changes in the Diversity of Nasopharynx Microbiota Based on Operational 
Taxonomic Units Analysis
Coverage of bacterial communities was high (mean 97.6% ± 
0.007%), with samples having an average of 161 OTUs (range 
63 to 321). The number of OTUs at each time point was not 
significantly different between groups (asymptomatic con-
trols vs ILI/Sflu+, P = .4425; Figure 2). Furthermore, the num-
ber of OTUs remained remarkably constant over time, even 
in the ILIflu+ group, with no significant difference compared 
with asymptomatic controls (Supplementary Figures  1 and 2; 
Ps = .5543 and .5836, respectively). The Chao 1 index measures 
the predicted richness of communities, so gives a higher value 
(median of 262 OTUs; range, 84 to 577 OTUs; Figure 2) than 
the recorded OTUs. The non-parametric estimator Catchall 
yielded a median of 437 OTUs per sample (range 66 to 2643). 
There were no significant differences in the richness of the 
between the ILI/Sflu+ group and asymptomatic control groups 
(Figure 2). Furthermore, there was no significant difference in 
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Figure 5. Relative abundance of common phyla in the human oropharynx. Comparison of the abundance of each phylum between individuals in the ILI/Sflu+ group (+) and the 
asymptomatic controls (-). The phyla are indicated in each panel. Error bars represent the standard deviation. A non-parametric Kruskal-Wallis test for multiple comparisons 
was applied to identify the statistically significant differences in relative abundances between groups. *P < .05. Samples are from individuals prior to their entry to quarantine 
(baseline) and at days 3, 6, and 28 after the challenge, or not (in the control group). Abbreviations: dpi, days post–influenza challenge; ILI/Sflu+, subjects who received viral 
challenge, had laboratory evidence of influenza, and had an influenza-like illness/were symptomatic.
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the richness of microbial communities in symptomatic indi-
viduals, even when comparing the ILI/Sflu+ group with the AC 
group (Supplementary Figures 1 and 2).
We also estimated the diversity of communities using the 
Shannon index. Again, no difference was detected between 
the challenged and control groups (Figure  2; Supplementary 
Figure  1 and 2), even when we analyzed the diversity of the 
communities in highly-symptomatic ILI subjects and asympto-
matic controls (Supplementary Table 1).
Next, we assessed differences between samples. 
Dendrograms were generated, highlighting similarities of the 
membership and structure of communities using Jaccard and 
thetaYC indices, respectively. At the 4 time points, results 
for certain individuals clustered together (eg, individual Sflu+ 
individual 2, ILIflu+6, Sflu+7, Sflu+10, ILIflu+11, Sflu+12, ILIflu+13, 
Sflu+17, ILIflu+28, AC61, and AC65), indicating that the indi-
vidual had a stronger influence on the microbiome than 
did influenza, with samples from 4 time points clustering 
together (Supplementary Figure 3). There was no significant 
clustering of OTUs either between groups or over time when 
we applied a parsimony test. The thetaYC index yielded a 
complex dendrogram (Supplementary Figure  4). Although 
there were no large shifts in the communities, minor changes 
were detected when we applied a parsimony test in the ILI/
Sflu+ and AC groups, with slight differences on days 3, 6, and 
28 (P <  .02, P <  .024, and P <  .001, respectively). However, 
these differences were not found after applying a Unifrac 
unweighted test.
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Figure 6. Relative abundance of common phyla in the human oropharynx. The abundance of phyla in individuals in the ILI/Sflu+ group (+). Phyla are indicated in each panel 
and error bars represent the standard deviation. A non-parametric Kruskal-Wallis test for multiple comparisons was applied to identify the statistically significant differences 
in relative abundances between groups. *P < .05; **P < .01. Samples are from individuals prior to their entry to quarantine (baseline) and at days 3, 6, and 28 after the 
challenge. Abbreviations: dpi, days post–influenza challenge; ILI/Sflu+, subjects who received viral challenge, had laboratory evidence of influenza, and had an influenza-like 
illness/were symptomatic.
D
ow
nloaded from
 https://academ
ic.oup.com
/cid/advance-article-abstract/doi/10.1093/cid/ciy821/5184302 by U
niversity C
ollege London user on 14 D
ecem
ber 2018
 • CID 2018:XX (XX XXXX) • 7URT Microbiome and Influenza
The community structure and membership was also visual-
ized by PCoA (Figure 3). Small differences were found in the 
structure of communities in the ILI/Sflu+ and AC groups at 
day 3 and day 6 (P < .035 and P < .033, respectively; Figure 3). 
Differences were not found in the memberships. The com-
munity structure was also examined for each group over time 
(Supplementary Figure 5); at day 6, the ILI/Sflu+ group showed 
a statistically significant difference compared to baseline 
(P < .036), while in the AC group, days 3, 6, and 28 each showed 
some statistically significant difference compared to baseline 
(P < .001), indicating that quarantine might have effects on the 
URT microbiome.
By LDA effect size analysis, the abundance of some OTUs 
was significantly different between groups on days 3 and 6 
post-infection (Figure  4). The OTUs which were more abun-
dant within the ILI/Sflu+ group at day 3 included OTU11 
(Prevotella melaninogenica), OTU14 (Leptotrichia), OTU38 
(Human Oral Taxon 352), and OTU38 (Porphyromonas), while 
OTU42 (Burkholdiales) and OTU6 (Leptotrichia HOT218) 
were more abundant within the AC group. At day 6, OTU18 
(Fusobacterium necrophorum) and OTU37 (Prevotella) were 
significantly more abundant in individuals in the ILI/Sflu+ group.
Alteration in the Ecology of the Pharyngeal Microbiome During Influenza
Next, we examined the communities by phylum. Of 2 057 548 
sequences, 19 416 could not be classified, with the remainder 
distributed into 11 phyla. A  total of 97.1% of the sequences 
belonged to only 5 phyla: Actinobacteria (7.9%), Fusobacteria 
(24.2%), Firmicutes (36.5%), Bacteroidetes (14.1%) or 
Proteobacteria (14.4%). We detected Spirochaetes, Synergistetes, 
Tenericutes, GN02, and 2 uncultured prokaryotes (TM7 and 
SR1) each at <1% of the total microbiota.
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Figure 7. Relative abundance of the common genera in the human oropharynx. Comparison of the abundance of each phylum in individuals between the ILI/Sflu+ group 
(+) and the asymptomatic controls (-). Genera are indicated in each panel. Error bars represent the standard deviation. A non-parametric Kruskal-Wallis test for multiple 
comparisons was applied to identify the statistically significant differences in relative abundances between groups. *P < .05. Samples are from individuals prior to their entry 
to quarantine (baseline) and at days 3, 6, and 28 after the challenge, or not (in the control group). Abbreviations: dpi, days post–influenza challenge; ILI/Sflu+, subjects who 
received viral challenge, had laboratory evidence of influenza, and had an influenza-like illness/were symptomatic.
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The abundance of each phylum remained remarkably con-
stant following the influenza challenge. There was a significant 
change in the Bacteroidetes levels, which increased in the ILI/
Sflu+ group at day 3 post-infection, as compared to the AC group 
(Figure 5). We also analyzed changes over the time. Within the 
ILI/Sflu+ group, there was a significant change in the abundance 
of Actinobacteria, which increased by day 6 compared to base-
line (P < .01) and returned to basal levels by day 28 (Figure 6). 
Firmicutes levels also increased between days 6 and 28 post-in-
fection in the control group (Supplementary Figure 6), with an 
increase in Streptococcus (Supplementary Figure  7) that coin-
cided with individuals returning to the community; this might 
reflect changes in social behaviors.
With regard to the genus level, Streptococcus was a core 
component of the microbiome, accounting for 21.8% of bac-
teria, with Fusobacterium and Prevotella also abundant (com-
prising 15.4% and 9.9%, respectively). Neisseria, Haemophilus, 
and Campylobacter each accounted for 2–5% of the microbiota 
(Figure  7). Differences were identified between the ILI/Sflu+ 
and AC groups (Figure  7), with a significant increase in the 
relative abundance of Prevotella on days 3 and 28 in the chal-
lenged group (P  <  .05) and an increase in Fusobacterium by 
day 28 in the challenged group (P <  .05). Within the ILI/Sflu+ 
group, a minor increase in Actinomyces was observed at day 6 
post-infection (P < .05) and, in parallel, Haemophilus decreased 
(P < .01; Figure 8).
S. pneumoniae and N. meningitidis Carriage Is Unaltered During Influenza
As 16S sequencing often cannot discriminate different species, 
we analyzed the carriage of 2 important respiratory pathogens: 
S. pneumoniae and N. meningitidis. The rate of colonization by 
encapsulated or non-encapsulated N. meningitidis was similar, 
with no difference between challenged and control individuals 
(Figure  9). For S.  pneumoniae, 16 of 36 influenza-challenged 
subjects (31%) and 12 of 23 controls (34%) were positive for 
S. pneumoniae, using qPCR, at day 3 (P = .8163).
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Figure 8. Relative abundance of the common genera in the human oropharynx. The abundance of each genera in individuals within the ILI/Sflu+ group (+). The genera are 
indicated in each panel. Error bars represent the standard deviation. A non-parametric Kruskal-Wallis test for multiple comparisons was applied to identify the statistically 
significant differences in relative abundances between groups. *P < .05. Samples are from individuals prior to their entry to quarantine (baseline) and at days 3, 6, and 28 
after the challenge. Abbreviations: dpi, days post–influenza challenge; ILI/Sflu+, subjects who received viral challenge, had laboratory evidence of influenza, and had an 
influenza-like illness/were symptomatic.
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DISCUSSION
We performed the first prospective characterization of bacterial 
communities within the human URT during influenza infec-
tion. Previous studies have examined changes in the microbi-
ota following challenges with other viruses [25, 26], and found 
only minor changes in certain bacterial genera. Furthermore, 
cross-sectional studies have characterized the microbiomes of 
patients with influenza [42]. However we are not aware of a pre-
vious study that examined individuals during a defined influ-
enza challenge.
We detected slight perturbations in the upper respiratory 
microbiota following a challenge with influenza A. There was 
a high level of inter-individual variation in the upper respira-
tory microbiome, a common feature of human studies [27]. 
We found that the microbiota contains at least 11 phyla, with 
5 (Actinobacteria, Firmicutes, Fusobacteria, Bacterioidetes, 
and Proteobacteria) constituting the core microbiome, as in 
a previous study [26], and with Fusobacteria highly prevalent 
(accounting for 24.2% of all OTUs) [20].
The microbiotas were dominated by Streptococcus and 
Fusobacteria, which include species that can cause influen-
za-associated pulmonary disease. However, during the acquisi-
tion of influenza, the profile of the URT microbiome remained 
remarkably stable. Although we detected no large shift in the 
bacterial population at the genus level, there was an increase 
in the abundance of Prevotella in the ILI/Sflu+ group at days 3 
and 28, a key time of secondary bacterial infection; although 
P.  melaninogenica was associated with this increase, little is 
known about its role in respiratory disease.
Overall, our study does not provide evidence that influenza 
infection has a marked impact in shaping the pharyngeal micro-
biome. However, certain factors might be responsible for this. 
Participants were healthy adults, who do not generally suffer sec-
ondary bacterial infections; studies in at-risk individuals might 
reveal more significant changes in the microbiome, although 
they would pose serious ethical issues. In addition, other effects 
might become evident in a larger study. Furthermore, 16S 
rRNA–based methods are limited, lacking species-level resolu-
tion for particular genera, including Streptococcus and Neisseria. 
Even though cohort studies have established a relationship 
between influenza and the rate of pneumococcal carriage, we 
did not find differences in pneumococcal carriage following an 
influenza infection. For the meningococcus, we also examined 
capsule expression, as this virulence factor is only expressed by 
a subset of strains [43]. However, there was no alteration in the 
rate of carriage of encapsulated or non-encapsulated N. men-
ingitidis with the advent of an influenza infection. We did not 
examine swabs for the presence of S. aureus, as this secondary 
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Figure 9. Neisseria meningitidis carriage following the influenza challenge. Meningococcal carriage in (A) the ILI/Sflu+ group and (B) the asymptomatic control group at 
different times following the challenge. The carriage of non-groupable N. meningitidis was unchanged during influenza infection and ranged between 11.4 and 13.5%, except 
for control samples from days 6 and 28. There was no change in the carriage of groupable N. meningitidis over time or between groups. Abbreviation: ILI/Sflu+, subjects who 
received viral challenge, had laboratory evidence of influenza, and had an influenza-like illness/were symptomatic.
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bacteria pathogen follows influenza far less frequently than 
S. pneumoniae and is associated with severe disease rather than 
milder infections, such as that represented by our challenge.
In conclusion, our findings demonstrate that the upper air-
way microbiota is not reprogrammed by influenza infection, 
with only minor perturbations in bacterial communities, sim-
ilar to recent findings with rhinovirus [44]. Further studies are 
required to examine the cross-kingdom interactions that are 
responsible for secondary bacterial infection being a key player 
in the mortality and morbidity associated with influenza.
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